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Abstract
Background: Nitric oxide (NO) shows differing concentrations in lower and upper airways. Patients after total
laryngectomy are the only individuals, in whom a complete separation of upper and lower airways is guaranteed.
Thus the objective of our study was to assess exhaled and nasal NO in these patients.
Methods: Exhaled bronchial NO (FENO) and nasal nitric oxide (nNO) were measured in patients after total
laryngectomy (n = 14) and healthy controls (n = 24). To assess lung function we additionally performed spirometry.
Co-factors possibly influencing NO, such as smoking, infections, and atopy were excluded.
Results: There was a markedly (p < 0.001) lower FENO in patients after total laryngectomy (median (range): 4 (1-22)
ppb) compared to healthy controls 21 (9-41) ppb). In contrast, nNO was comparable between groups (1368 versus
1380 in controls) but showed higher variability in subjects after laryngectomy.
Conclusions: Our data suggest that either bronchial NO production in patients who underwent laryngectomy is
very low, possibly due to alterations of the mucosa or oxidant production/inflammation, or that substantial
contributions to FENO arise from the larynx, pharynx and mouth, raising FENO despite velum closure. The data fit to
those indicating a substantial contribution to FENO by the mouth in healthy subjects. The broader range of nNO
values found in subjects after laryngectomy may indicate chronic alteration or oligo-symptomatic inflammation of
nasal mucosa, as frequently found after total laryngectomy.
Background
The fraction of exhaled bronchial nitric oxide (FENO)
has emerged as an important non-invasive marker of
airway inflammation since its discovery in exhaled air by
Gustafsson in 1991 [1]. The assessment of FENO is
increasingly used in clinical practice, especially for mon-
itoring eosinophilic airway inflammation. Compared to
bronchial NO, the measurement of nasal nitric oxide
(nNO) has been methodologically and clinically less
intensively studied. Since its first description in 1993, it
has been proposed that the highest contribution to nNO
originates from the paranasal sinuses [2]. nNO exceeds
FENO by factors of 10 to 100, depending on the sam-
pling method used. As even slight contaminations by
nasal NO greatly affect the level of exhaled NO, it is
essential to exclude the upper airways when determining
FENO. In clinical practice this is done by closing the soft
palatine/velum while subjects exhale against a flow resis-
tance through the mouth.
In patients after total laryngectomy upper and lower
airways are anatomically separated and thus they are
ideally suited for separate assessments of NO in these
two compartments. Currently there are no studies on
both FENO a n dn N Oi nt h e s es u b j e c t s .T h em e a s u r e -
ments are of interest, since numerous factors can influ-
ence FENO, such as respiratory tract inflammation,
atopy, smoking, drugs, gender, age, and height [3].
There are data indicating a substantial contribution to
FENO arising from the mouth in healthy subjects [4]. On
the other hand patients after laryngectomy show ultra-
structural alterations of the lower respiratory tract -
comparable to long-term tracheotomized, never-smok-
ing patients [5] - likely due to the fact that they directly
inhale ambient air. Same is reported for alterations
within their nasal mucosa [6,7]. * Correspondence: matthias.kramer@med.uni-muenchen.de
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and nasal NO in such patients with anatomically sepa-
rated lower and upper airways. For comparison we
included a group of healthy individuals.
Methods
Patients
The study was performed in cooperation between the
Department of Oto-Rhino-Laryngology, Head and Neck
surgery and the Institute and Outpatient Clinic for
Occupational, Social and Environmental Medicine, both
Ludwig-Maximilians-University, Munich, Germany. The
study was approved by the institutional Ethic Commit-
tee, and subjects gave written informed consent. Specific
exclusion criteria for this study comprised: atopy
assessed by a screening test (see below), smoking, cur-
rent respiratory tract infections, and anti-inflammatory
drug intake assessed by questionnaire.
14 patients after total laryngectomy could be recruited.
The median (range) time since laryngectomy had been
performed was 6 (2-24) years before the study. Laryn-
gectomy was done due to T3 or T4 squamous cell carci-
noma of the larynx or hypopharynx. All patients
underwent accelerated, adjuvant radiochemotherapy
after surgery. By enrollment into the study all of them
had at least 2 years of carcinoma-free survival and nega-
tive staging results, thus no signs of regional carcinoma,
metastasis or second carcinoma such as bronchial
cancer.
Patients were well adapted to their physical impair-
ments arising from laryngectomy (e.g. permanent tra-
cheotomy, impairment of speech, smell). They were
asked concerning other diseases and symptoms by ques-
tionnaire. None of them reported a diagnosis or typical
symptoms of asthma, atopic diseases, or nasal patholo-
gies, e.g. polyposis or chronic rhinosinusitis. Before sur-
gery all but one patient had been smokers with a
median (range) of 22.75 (0-83) pack years. After surgery
all of them refrained from smoking. As controls we
measured 24 healthy, non-atopic, non-smoking indivi-
duals. For subjects’ characteristics see table 1.
Measurement of nitric oxide
Due to logistic and technical reasons, FENO was deter-
mined in control subjects using a handheld electroche-
mical analyzer (NIOX mino, Aerocrine, Sweden), and in
patients with total laryngectomy by a chemilumines-
cence analyzer NOA 280™ ( S i e v e r s ,B o u l d e r ,C o ,U S A ) .
These two types of analyzers have been shown to yield
comparable results [8], and measurements were per-
formed according to international guidelines [3]. There
are however some data indicating a systematic difference
between the two types of analyzers [9]. Thus we addi-
tionally compared the two devices in 15 subjects and
found that geometric mean values were 27.1 and 26.4
ppb, respectively, with a Pearson correlation coefficient
of 0.99. The mean difference between FENO values
obtained by both methods was 1.1 ppb, the 95% limits
of agreement were -6.3 and 8.5 ppb. Thus we consid-
ered the devices to be comparable.
Subjects exhaled through a mouthpiece against a posi-
tive pressure of around 10 cm H2O, aiming to achieve a
flow rate of 50 mL/s under visual control on a computer
screen or the display of the handheld device. The analy-
zer was calibrated regularly using a certified calibration
gas (Linde AG, Munich, Germany). Measurements were
performed in triplicate. In patients with total laryngect-
omy FENO was assessed by exhaling into the analyzer,
while the tracheostoma was hermetically sealed by com-
mercially available tracheotomy plaster, designed to be
connected to speech prostheses (Provox® Xtra-Base™,
Atos Medical, Hörby, Sweden). When connecting the
analyzer to the plaster we checked for a gas-tight fitting.
Using this approach it was possible to measure easily
and reproducibly FENO in the patients.
Additionally nasal NO was determined in all patients
after laryngectomy and in a subgroup of the healthy
subjects (n = 11). Nasal NO was assessed by the chemi-
luminescence analyzer putting a nasal olive in one nos-
tril, with the other nostril open and using a suction flow
Table 1 subjects’ characteristics
Patients after total laryngectomy
(n = 14)
Healthy controls
(n = 24)
Sex (m/w) 12/2 13/11
Age (years) 64 (46-77) 37 (20-73) *
Height (cm) 174 (160-190) 171 (158-195)
Weight (kg) 75 (44-110) 69 (53-100)
IVC (% predicted) 97 (78-126) 103 (71-164)
FEV1 (% predicted) 98 (56-132) 106 (78-166) *
FEV1/IVC (% predicted) 104 (62-128) 106 (85-118)
Subjects’ characteristics, displayed as absolute values or median (range).
IVC = maximal inspired vital capacity, FEV1 = forced expiratory volume in one second, * = p < 0.05
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was secured by slow oral expiration against a resistance
that ensured a minimum pressure of 5 cmH2O. nNO
was assessed when a plateau was reached. Measure-
ments were performed in triplicate for each nostril and
mean values of both nostrils were used for analysis.
Velum closure was not necessary in patients after total
laryngectomy due to surgical separation of upper and
lower airways.
Spirometry
After NO measurements spirometry was performed fol-
lowing established guidelines [10] using a pneumotacho-
graph-based device (Masterscope™, Viasys Health Care
GmbH, Höchberg, Germany). We recorded maximal
inspired vital capacity (IVC), forced expiratory volume
in one second (FEV1), and FEV1/IVC. Values were
expressed as percent predicted using the European
Respiratory Society reference values [11]. At least three
technical acceptable flow-volume maneuvers were per-
formed and the highest values were taken. In patients
after total laryngectomy we connected the tracheotomy
to the spirometer in the same way as described for
FENO.
Atopy screening test
Atopy was excluded by history and/or a positive allergy
screening test SX1 (Phadiatop®, Phadia, Freiburg, Ger-
many). The sensitivity of this screening method is
greater than 96% [12].
Statistical analysis
As FENO values are known to have a skewed distribution
and due to the low number of subjects in the groups
data are generally displayed as median (range). For nNO
values, which were calculated as the mean of 6 single
measurements (3 from each nostril) coefficients of varia-
tion are shown. For statistical comparisons between
groups Fisher’s exact test or Mann-Whitney-U-Test
were used. P-values < 0.05 were considered statistically
significant. Calculations were performed using SPSS
16.0 (SPSS Inc., Chicago, IL).
Results
Patients’ characteristics
There was a significant difference concerning age (med-
ian age 64 versus 37 y; table 1) between patients after
laryngectomy and healthy controls, otherwise both
groups were comparable concerning gender, weight, and
height. Additional factors possibly influencing NO, such
as atopy, anti-inflammatory drugs, smoking, and infec-
tions had been excluded prior to enrolment in all
subjects.
Exhaled nitric oxide
FENO values in control subjects were within the normal
range of healthy individuals with a median (range) of 21
(9-41) ppb. In patients after total laryngectomy median
FENO was 4 (1-22), and thus significantly (p < 0.001)
lower (figure 1). In the patients only 2 subjects (14%)
had FENO values > 9 ppb, whereas in the controls only
one subject (4%) had a value < 10 ppb.
Nasal nitric oxide
The median (range) coefficients of variation of the single
6-fold measurements of nNO were 11.1 (0.7-30.6) in the
patients and 5.4 (0.8-25.2) in healthy subjects (n.s.).
Nasal nitric oxide was 1368 (431-2028) ppb in patients
after total laryngectomy and 1380 (988-2097) ppb in
healthy controls (n.s.). As displayed in figure 2, the
variability of nNO values was more pronounced in the
patients, including some low values in the range of 500
ppb.
Spirometry
I V Ca sw e l la sF E V 1/IVC in terms of %predicted values
were comparable between groups, whereas FEV1 %pred
Figure 1 Exhaled bronchial nitric oxide (FENO) in patients after
total laryngectomy and healthy control subjects.
Figure 2 Nasal nitric oxide (nNO) in patients after total
laryngectomy and healthy control subjects.
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table 1). Four patients (29%) had a FEV1 < 80%pred.
Discussion
The present study demonstrated a significantly
decreased level of FENO in patients after laryngectomy
compared to healthy control subjects, whereas nNO was
similar between groups with a broader range of values
in the subjects after laryngectomy. Total laryngectomy,
with consecutive elimination of the climate function of
the nose, might result in functional and structural
changes of the lower airways, as described mainly within
the first 6 months after surgery [13]. So far there are no
data about the long-term effect this might have on
exhaled NO. Our data suggest that bronchial NO pro-
duction might be lowered in these patients, possibly due
to alterations of the mucosa due to the exposure to
inhaled dry ambient air that has not been humidified
and filtered by the upper airways. However, two of the
subjects after laryngectomy had FENO values > 9 ppb
(17 and 22 ppb) and thus in the range of the healthy
controls. In those two patients laryngectomy had been
performed 22 and 24 years before the study, the longest
time periods of all participants. Eleven of the remaining
12 subjects had their operation within the last 12 years
before the study and all of them had FENO values below
10 ppb. The rise in FENO only after a very long time
since the laryngectomy had been performed may point
to additional long term changes in the physiology of the
mucosa.
On the other hand, the reduction of FENO values
might have been due to exclusion of other NO sources
within the upper airways. There might be substantial
contributions to exhaled NO originating from the lar-
ynx, pharynx and/or oral cavity. In line with this,
mouth-washing reduced FENO up to 50% [4], while
intake of nitrate-rich food elevates FENO [14]. Moreover,
data obtained in trachetomized patients have indicated
significant contributions from oral compared to tracheal
sources [15,16]. We are not aware of studies in which
laryngeal or pharyngeal contributions to FENO have
been directly determined. FENO assessed in orally
exhaled air is thought to be primarily of bronchial ori-
gin. This is based on the fact that bronchial NO much
exceeds alveolar NO, and that contaminations by nasal
NO are excluded by functional separation of lower air-
ways and the nasal cavity. This is achieved by closing
the velum when exhaling against a resistance, thereby
preventing NO from nasal and paranasal sources from
entry into the exhaled air. Our data might additionally
indicate that the procedure of velum closure is not suffi-
cient to assess bronchial NO without bias. However,
these findings and hypothesis do not question the value
of FENO as a biomarker of eosinophilic bronchial
inflammation, which has been shown in numerous stu-
dies [3]. As we did not include subjects with laryngect-
omy plus asthma, allergic rhinitis or atopy no further
conclusions about the diagnostic value of FENO in those
patients can be drawn.
The comparison of the two groups has to deal with a
number of factors that are known to influence FENO.
Among these are airway inflammation, smoking, steroid
therapy, age, gender, and height [3]. While we tried to
minimize their impact by the inclusion criteria, still
some differences inevitably remained. In some respects
a better match of patients and controls would have been
preferable. Control subjects were younger than patients.
Consequently we cannot exclude an effect of age on our
results. An increase of FENO with age has been found
[17], while other studies did not reveal such a depen-
dence [18]. Based on the available data, the effect of age
would be very small and values in the group of patients
should have been even elevated.
Smoking habits in the past differed between the two
groups but at the time of the study none of the subjects
smoked. Smoking is a risk factor for laryngeal cancer,
and all but one of the carcinoma patients had smoked
before surgery. This may have lead to alterations in lung
function or chronic obstructive pulmonary disease
(COPD). Indeed, FEV1 %pred was lower in patients after
total laryngectomy, four patients having a FEV1 <8 0 %
pred, possibly indicating COPD. None of the subjects
received any respiratory medication. Notably, results
concerning FENO in COPD are conflicting and most
authors found elevated FENO values [19-21] Smoking is
known to decrease FENO,a n dF E NO has been reported
to differ between never- and ex-smokers [22]. In con-
trast, a large population-based study did not find such a
difference [17]. Moreover, it is known that in subjects
quitting smoking FENO increases to about the level mea-
sured in normal non-smokers within 1-8 weeks after
cessation [23,24]. All of the patients after total laryn-
gectomy had stopped smoking after surgery for at least
2 years. Thus, the pronounced difference in FENO
between our groups cannot be explained by the smoking
status.
As increased levels of FENO have been reported in
lung cancer [25], we enrolled only patients with at least
2 years of carcinoma-free survival. All of them were well
adapted to their impairment due to laryngectomy and
t h e r ew e r en os i g n so fr e c u r r e n tc a r c i n o m ao fa n yt y p e .
As a result of the inclusion criteria, which aimed at
minimizing other possible influences on FENO,w e
included only 14 patients after laryngectomy. As alterna-
tive therapeutic approaches for T3 or T4 carcinoma of
the larynx or hypopharynx, such as modified surgical
techniques and powered instruments such as LASER,
are increasingly used, the number of total laryngectomy
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rate <40%) despite numerous modifications over the last
decades. We consider as strengths of our work the use
of homogeneous, well defined groups, enabling the
detection of differences in FENO even in a small sample.
There is one study which has aimed at separating the
lower and upper airways by measuring neurological
patients with tracheotomy who are usually tracheoto-
mized in order to prevent aspiration [15]. In these
patients, even cannula with inflated cuffs cannot avoid
silent aspiration, and consecutively pneumonia with an
impact on FENO. Three out of the 10 patients studied
previously even used silver cannula without inflatable
cuff. The only situation, in which lower and upper air-
ways are guaranteed to be fully separated, is total laryn-
gectomy. The data of the present study are in line with
that of the previous study. A second study also found
significanty lower FENO values in 5 patients with tra-
cheostomy when exhaling through the tracheostomy
compared to exhaling through the mouth [16]. Future
studies may additionally apply extended NO analysis for
a better characterization of the NO exchange in those
patients [26]. Hypothetically the diffusion rate of NO
could be decreased due to thickness of the mucosa
whereas the level of NO in the airway tissue might be
normal. Another possible explanation for the low FENO
values in the patients may be a higher oxidative stress
due to an inflamed epithelium of the bronchial mucosa.
Regarding nasal NO we observed a broader range of
values in patients. Nasal function and anatomy are
known to change after laryngectomy due to the lack of
ventilation, and in CT scans of paranasal sinuses muco-
sal swelling is a regular finding [6,7,27,28]. Deniz et al.
describe a hypersecretory phase with increased nasal
mucosal clearance in the early period after laryngectomy
and an atrophy of the nasal mucosa with decreased
clearance later [6]. A second study also found increased
nasal and bronchial mucociliary clearance in the first
months after laryngectomy and a decrease 6 years after
surgery [28]. Generally a variety of changes, including
also subclincal, ongoing nasal inflammation may affect
nNO and thus explain the larger variation compared to
the healthy subjects. Furthermore the coefficients of var-
iation were somewhat, but not statistically significant
higher in the patients, indicating less precise measure-
ments in those subjects. None of the subjects reported
nasal pathologies, e.g. polyposis or chronic rhinosinusits.
However, as we did not perform endoscopy or com-
puted tomography during the current visit we cannot
rule out completely nasal pathologies. Clinically silent
polyposis or hypertrophy of turbinates thus might
explain part of the variability of nNO found in laryngec-
tomized patients [29]. Further studies with more sub-
jects are warranted to correlate nNO with
morphological changes after laryngectomy. To better
characterize the inflammatory processes in the bronchial
and nasal mucosa of patients with laryngectomy those
studies should also include an assessment of neutrophi-
lic inflammation, e.g. by measuring H2O2 or interleukins
involved in the neutrophilic response in exhaled breath
condensate. As additional clinical implication for
patients after total laryngectomy, our findings indicate
that it is well possible to measure exhaled and nasal NO
and to perform spirometry in these patients using stan-
dard equipment.
Conclusion
In conclusion, we studied patients after total laryngect-
omy as an in vivo model, in which a complete separa-
tion of lower and upper airways is guaranteed. Using
strict definition of inclusion criteria in order to mini-
mize factors influencing NO, we found markedly lower
FENO in patients after total laryngectomy compared to
h e a l t h yc o n t r o l s .T h e s ed a t am i g h ti n d i c a t et h a tt h e
functional separation of l o w e ra n du p p e ra i r w a y si n
healthy individuals by velum closure does not suffice to
assess bronchial NO without bias and/or that bronchial
nitric oxide would be lower than measured by the rou-
tine method, since NO originating from the larynx,
pharynx and/or mouth would contribute to exhaled NO.
However, substantial alterations of the bronchial mucosa
as a consequence of total laryngectomy might be a
further explanation.
Acknowledgements
The data represent part of the medical doctoral thesis of Annette Bihler.
Author details
1Department of Oto-Rhino-Laryngology, Head- and Neck Surgery, Ludwig-
Maximilians-University, Munich, Germany.
2Institute and Outpatient Clinic for
Occupational, Social and Environmental Medicine, Ludwig-Maximilians-
University, Munich, Germany.
Authors’ contributions
All authors read and approved the final manuscript. MK and HD: designed
the study, analysed and interpret the data, and did the drafting of the
manuscript. Further both supervised the study. BO, AB, and DM: were
responsible for the recruitment of patients, conducted the measurements
and gave substantial contribution to the conception of the study. DN: gave
substantial contribution to the design of the study, interpretation of data,
revised the manuscript critically. RJ: gave substantial contribution to the
design of the study and interpretation of data. Furthermore he provided
advice for physiological or statistical questions.
Competing interests
The authors declare that they have no competing interests.
Received: 18 August 2009
Accepted: 28 January 2010 Published: 28 January 2010
References
1. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S:
Endogenous nitric oxide is present in the exhaled air of rabbits, guinea
pigs and humans. Biochem Biophys Res Commun 1991, 181:852-857.
Kramer et al. BMC Pulmonary Medicine 2010, 10:4
http://www.biomedcentral.com/1471-2466/10/4
Page 5 of 62. Alving K, Weitzberg E, Lundberg JM: Increased amount of nitric oxide in
exhaled air of asthmatics. Eur Respir J 1993, 6:1368-1370.
3. American Thoracic Society Documents: ATS/ERS recommendations for
standardized procedures for the online and offline measurement of
exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir
Crit Care Med 2005, 171:912-930.
4. Zetterquist W, Pedroletti C, Lundberg JO, Alving K: Salivary contribution to
exhaled nitric oxide. Eur Respir J 1999, 13:327-333.
5. Roessler F, Grossenbacher R, Walt H: Effects of tracheostomy on human
tracheobronchial mucosa: a scanning electron microscopic study.
Laryngoscope 1988, 98:1261-1267.
6. Deniz M, Uslu C, Ogredik EA, Akduman D, Gursan SO: Nasal mucociliary
clearance in total laryngectomized patients. Eur Arch Otorhinolaryngol
2006, 263:1099-1104.
7. Fisher EW, Lund VJ, Rutman A: The human nasal mucosa after deprivation
of airflow: a study of laryngectomy patients. Rhinology 1992, 30:5-10.
8. Alving K, Janson C, Nordvall SL: Performance of a new hand-held device
for exhaled nitric oxide measurement in adults and children. Respir Res
2006, 20:67.
9. Pizzimenti S, Bugiani M, Piccioni P, Heffler E, Carosso A, Guida G, Rolla G:
Exhaled nitric oxide measurements: correction equation to compare
hand-held device to stationary analyzer. Respir Med 2008, 102:1272-1275.
10. American Thoracic Society Documents: ATS/ERS standardization of lung
function testing: standardization of spirometry. Am J Respir Crit Care Med
2005, 26:319-338.
11. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC:
Lung volumes and forced ventilartory flows. Report working party
standardization of lung function tests, European Community for steel
and coal. Official statement of the European Respiratory Society. Eur
Respir J (Suppl) 1993, 16:5-40.
12. Kohl C, Debelic M: In vitro screening for inhalant allergy with multi SX 1
RAST (Phadiatop). Allergy 1991, 46:245-250.
13. Ackerstaff AH, Hilgers FJ: Sequelae of total laryngectomy with special
reference to rehabilitation of the voice and the lower airways. HNO 1997,
45:97-104.
14. Olin AC, Aldenbratt A, Ekman A, Ljungkvist G, Jungersten L, Alving K,
Toren K: Increased nitric oxide in exhaled air after intake of a nitrate-rich
meal. Respir Med 2001, 95:153-158.
15. Tornberg DC, Marteus H, Schedin U, Alving K, Lundberg JO, Weitzberg E:
Nasal and oral contribution to inhaled and exhaled nitric oxide: a study
in tracheotomized patients. Eur Respir J 2002, 19:859-864.
16. Schedin U, Frostell C, Persson MG, Jakobsson J, Andersson G, Gustafsson LE:
Contribution from upper and lower airways to exhaled endogenous
nitric oxide in humans. Acta Anaesthesiol Scand 1995, 39:327-332.
17. Olin AC, Rosengren A, Thelle DS, Lissner L, Bake B, Toren K: Height, age,
and atopy are associated with fraction of exhaled nitric oxide in a large
adult general population sample. Chest 2006, 130:1319-1325.
18. Olivieri M, Talamini G, Corradi M, Perbellini L, Mutti A, Tantucci C,
Malerba M: Reference values for exhaled nitric oxide (reveno) study.
Respir Res 2006, 7:94.
19. Delen FM, Sippel JM, Osborne ML, Law S, Thukkani N, Holden WE:
Increased exhaled nitric oxide in chronic bronchitis: comparison with
asthma and COPD. Chest 2000, 117:695-701.
20. Ansarin K, Chatkin JM, Ferreira IM, Gutierrez C, Zamel N, Chapman KR:
Exhaled nitric oxide in chronic obstructive pulmonary disease:
relationship to pulmonary function. Eur Respir J 2001, 17:934-938.
21. Ferreira IM, Hazari MS, Gutierrez C, Zamel N, Chapman KR: Exhaled nitric
oxide and hydrogen peroxide in patients with chronic obstructive
pulmonary disease: effects of inhaled beclomethasone. Am J Respir Crit
Care Med 2001, 164:1012-1015.
22. Malinovschi A, Janson C, Holmkvist T, Norbäck D, Meriläinen P, Högman M:
Effect of smoking on exhaled nitric oxide and flow-independent nitric
oxide exchange parameters. Eur Respir J 2006, 28:339-345.
23. Robbins RA, Millatamal T, Lassi K, Rennard S, Daughton D: Smoking
cessation is associated with an increase in exhaled nitric oxide. Chest
1997, 112:313-318.
24. Högman M, Holmkvist T, Walinder R, Meriläinen P, Ludviksdottir D,
Hakansson L, Hedenström H: Increased nitric oxide elimination from the
airways after smoking cessation. Clin Sci (Lond) 2002, 103:15-19.
25. Masri FA, Comhair SA, Koeck T, Xu W, Janocha A, Ghosh S, Dweik RA,
Golish J, Kinter M, Stuehr DJ, Erzurum SC, Aulak KS: Abnormalities in Nitric
Oxide and Its Derivatives in Lung Cancer. Am J Respir Crit Care Med 2005,
172:597-605.
26. George SC, Hoegman M, Permutt S, Silkoff PE: Modeling pulmonary nitric
oxide exchange. J Appl Physiol 2004, 96:831-839.
27. Calderazzi A, Vaglini F, Baschieri D, Bruno R, Donati F, Sbragia-Daddi C:
Radiological changes in the nasal and paranasal cavities of patients
having undergone laryngectomy. Radiol Med (Torino) 1987, 74:396-398.
28. Maurizi M, Paludetti G, Almadori G, Ottaviani F, Todisco T: Mucociliary
clearance and mucosal surface characteristics before and after total
laryngectomy. Acta Otolaryngol 1986, 102:136-145.
29. Maniscalco M, Sofia M, Weitzberg E, de Laurentiis G, Stanziola A, Rossillo V,
Lundberg JO: Humming-induced release of nasal nitric oxide for
assessment of sinus obstruction in allergic rhinitis: pilot study. Eur J Clin
Invest 2004, 34:555-560.
Pre-publication history
The pre-publication history for this paper can be accessed here:http://www.
biomedcentral.com/1471-2466/10/4/prepub
doi:10.1186/1471-2466-10-4
Cite this article as: Kramer et al.: Exhaled and nasal nitric oxide in
laryngectomized patients. BMC Pulmonary Medicine 2010 10:4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Kramer et al. BMC Pulmonary Medicine 2010, 10:4
http://www.biomedcentral.com/1471-2466/10/4
Page 6 of 6